APP and Alzheimer disease: Hou et al. conducted a study using an APP/PS1 mutant mouse model of AD and used the nicotinamide adenine dinucleotide (NAD) precursor nicotinamide riboside (NR) as a treatment and found significantly elevated levels of NLRP3 inflammasome in APP/PS1 mutant mice.